ES2112562T3 - Nuevo difenilhexeno. - Google Patents

Nuevo difenilhexeno.

Info

Publication number
ES2112562T3
ES2112562T3 ES94926896T ES94926896T ES2112562T3 ES 2112562 T3 ES2112562 T3 ES 2112562T3 ES 94926896 T ES94926896 T ES 94926896T ES 94926896 T ES94926896 T ES 94926896T ES 2112562 T3 ES2112562 T3 ES 2112562T3
Authority
ES
Spain
Prior art keywords
new
difenilhexeno
treatment
hexene
psoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94926896T
Other languages
English (en)
Inventor
Reinhard Pechan
Manfred Metzler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934328965 external-priority patent/DE4328965A1/de
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2112562T3 publication Critical patent/ES2112562T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
    • C07C15/40—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals
    • C07C15/50—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals polycyclic non-condensed
    • C07C15/52—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals polycyclic non-condensed containing a group with formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

EL NUEVO COMPUESTO 3,4 - DIFENIL - 3 - HEXENO POSEE PROPIEDADES FARMACEUTICAS VALIOSAS Y ES APROPIADO PARA TRATAMIENTO DE ENFERMEDADES, QUE ESTAN RELACIONADAS CON EL CRECIMIENTO CELULAR MORBIDO, EN PARTICULAR PARA TRATAMIENTO DE CANCER, PSORIASIS O SIDA.
ES94926896T 1993-08-27 1994-08-26 Nuevo difenilhexeno. Expired - Lifetime ES2112562T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19934328965 DE4328965A1 (de) 1992-04-15 1993-08-27 Neues Diphenylhexene

Publications (1)

Publication Number Publication Date
ES2112562T3 true ES2112562T3 (es) 1998-04-01

Family

ID=6496238

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94926896T Expired - Lifetime ES2112562T3 (es) 1993-08-27 1994-08-26 Nuevo difenilhexeno.

Country Status (7)

Country Link
US (1) US5650445A (es)
EP (1) EP0715613B1 (es)
JP (1) JPH09501926A (es)
AT (1) ATE162783T1 (es)
DE (1) DE59405189D1 (es)
ES (1) ES2112562T3 (es)
WO (1) WO1995006020A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4212628A1 (de) * 1992-04-15 1993-10-21 Manfred Dr Metzler Neue Bis-phenyl-hexene

Also Published As

Publication number Publication date
EP0715613B1 (de) 1998-01-28
EP0715613A1 (de) 1996-06-12
JPH09501926A (ja) 1997-02-25
ATE162783T1 (de) 1998-02-15
DE59405189D1 (de) 1998-03-05
WO1995006020A1 (de) 1995-03-02
US5650445A (en) 1997-07-22

Similar Documents

Publication Publication Date Title
CA2083179A1 (en) Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
NO20004803L (no) Smilagening og anzurogenin for behandling av Alzheimers sykdom
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
BR0315688A (pt) Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas
BR0114978A (pt) Composições e métodos que são úteis no tratamento de condições ou doenças inflamatórias, metabólicas, e proliferativas celulares
PT839154E (pt) Peptidos e composicoes biologicamente activos sua utilizacao
DE69132048D1 (de) Verwendung von Steroiden zur Inhibierung von Angiogenesis
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
ES8403884A1 (es) Un procedimiento para la preparacion de nuevos 2,3-diaril-5-halotiofenos.
RU94000064A (ru) Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции
ES2112562T3 (es) Nuevo difenilhexeno.
DK0538330T3 (da) Beta-Alethin-anvendelse til celledyrkning og terapi
FI960839A (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
ITRM920305A0 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 715613

Country of ref document: ES